Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
Highlights: Despite clinical evidence of its effectiveness in secondary prevention of cardiovascular disease, uptake of fixed dose combination therapy (FDCs) for CVD has been poor. A symposium was held bringing together stakeholders on this issue, including from academia, government and NGOs. The co...
Main Authors: | Ruth Webster, Adrianna Murphy, Helen Bygrave, Éimhín Ansbro, Diederick E. Grobbee, Pablo Perel |
---|---|
Format: | Article |
Language: | English |
Published: |
Ubiquity Press
2020-08-01
|
Series: | Global Heart |
Subjects: | |
Online Access: | https://globalheartjournal.com/articles/860 |
Similar Items
-
The Concept of the Polypill in the Prevention of Cardiovascular Disease
by: Brandon Wiley, et al.
Published: (2014-04-01) -
Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
by: Lilian Grigorian-Shamagian, et al.
Published: (2021-08-01) -
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients
by: Victoria Ros-Castelló, et al.
Published: (2020-11-01) -
Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01) -
Uso de la polipíldora cardiovascular en la prevención secundaria de la enfermedad cerebrovascular
by: J. Masjuan, et al.
Published: (2021-01-01)